Amgen Unusual Options Activity For August 29

BenzingaAug 29 15:48 ET

Vertex Pharmaceuticals's Options Frenzy: What You Need to Know

BenzingaAug 29 15:16 ET

Neurocrine Biosciences' Lower Dose Data Puts Its Schizophrenia Candidate In The Game, Analyst Upgrades Stock

BenzingaAug 29 13:22 ET

J&J Submits FDA Application for Myasthenia Gravis Drug Nipocalimab

Seeking AlphaAug 29 11:49 ET

Piper Ups Neurocrine to Overweight, Says '568 Still in the Game

Seeking AlphaAug 29 10:30 ET

Intuit, Amgen And Sprott Uranium Miners ETF: CNBC's 'Final Trades'

BenzingaAug 29 08:48 ET